Treating Familial Hypercholesterolemia: A Guide to Lowering Sky-High Cholesterol

Published: Jan 02, 2024

Familial hypercholesterolemia (FH) causes dangerously high cholesterol, but effective treatments are available. Learn how doctors tackle this genetic condition to protect heart health.

Statins: The First Line of Defense

High-dose statin medications are the cornerstone of FH treatment. These drugs, like atorvastatin or rosuvastatin, work by reducing the liver's cholesterol production. For many FH patients, statins can lower LDL cholesterol by 50% or more. However, they're often not enough on their own to reach target cholesterol levels.

Beyond Statins: Additional Medications

When statins aren't enough, doctors add other cholesterol-lowering drugs. Ezetimibe blocks cholesterol absorption in the intestines. PCSK9 inhibitors, given as injections, dramatically boost the body's ability to remove LDL from the blood. For severe cases, drugs like lomitapide may be used, though they can have significant side effects.

Familial hypercholesterolemia (FH) is a genetic condition characterized by high cholesterol levels, particularly LDL cholesterol, leading to an increased risk of heart disease.

LDL Apheresis: Filtering the Blood

Some FH patients, especially those with the more severe homozygous form, may need LDL apheresis. This procedure, similar to dialysis, filters LDL cholesterol directly from the blood. It's typically done every 1-2 weeks and can lower LDL levels by 60-70% each time.

Frequently Asked Questions

Doctors typically aim for LDL below 100 mg/dL, or even lower for high-risk patients.

Yes, FH requires lifelong management to control cholesterol levels.

Yes, treatment often starts in childhood, usually with statins.

Key Takeaways

With proper treatment, people with FH can significantly reduce their risk of early heart disease and live long, healthy lives.

Ready to take control of your FH? Consult with Doctronic about creating a personalized treatment plan.

Related Articles

References

Raal FJ, et al. Lancet. 2015;385(9965):331-340.

Cuchel M, et al. J Clin Lipidol. 2014;8(3 Suppl):S72-S81.

Always discuss health information with your healthcare provider.